2SE.F 0.94 (-11.32%)
BE0974340722Medical Devices & InstrumentsMedical Devices

Sequana Medical (2SE.F) Stock Highlights

0.94 | -11.32%
2024-07-25 06:19:50
Sequana Medical NV is a commercial-stage medical device company focused on the development of treatment solutions for the management of fluid overload in liver disease, malignant ascites, and heart failure. The companys products include alfapump, which provides a treatment solution for the long-term management of liver refractory ascites and malignant ascites with safety, efficacy, and quality of life benefits demonstrated in multiple clinical studies and over 750 implants. The companys geographical segments include Switzerland, Germany, the United Kingdom, and the Rest of the world, out of which Germany accounts for the majority of the revenue.

Statistics

Range Today
0.94 0.94
Volume Today 2.4K
Range 1 Year
1.06 4.69
Volume 1 Year 4.63K
Range 3 Year
1.06 8.22
Volume 3 Year 6.75K
Range 10 Year
1.06 9.5
Volume 10 Year 6.75K

Highlights

Market Capitalization 40.63M (micro)
Floating Shares 15.3M
Current Price 0.94
Price To Earnings -0.95
Price To Revenue 79.71
Earnings Per Share -1.22
Payout Ratio 0%

Performance

Latest -11.32%
1 Month -34.27%
3 Months -31.39%
6 Months -68.77%
1 Year -69.28%
3 Years -87.89%
5 Years -89.76%
10 Years -89.76%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.